BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37568625)

  • 1. Pattern Analysis of Serum Galectins-1, -3, and -9 in Breast Cancer.
    Funkhouser A; Shuster H; Martin JC; Edenfield WJ; Blenda AV
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer.
    Blair BB; Funkhouser AT; Goodwin JL; Strigenz AM; Chaballout BH; Martin JC; Arthur CM; Funk CR; Edenfield WJ; Blenda AV
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients.
    Markalunas EG; Arnold DH; Funkhouser AT; Martin JC; Shtutman M; Edenfield WJ; Blenda AV
    Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory Assessment of Galectin-1, -3, and -9 in Non-Small Cell Lung Cancer.
    Shuster H; Funkhouser A; Allen L; Heo M; Martin JC; Edenfield WJ; Blenda AV
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
    Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
    Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and Clinical Significance of Galcetin-3 in the Serum of Non-small Cell Lung Cancer Patients].
    Qi D; Zhang Y; Li H; Wang R; Qian K
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):333-336. PubMed ID: 32429635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 enhances trastuzumab resistance by regulating cancer malignancy and stemness in HER2-positive breast cancer cells.
    Chen Y; Xu J; Pan W; Xu X; Ma X; Chu Y; Wang L; Pang S; Li Y; Zou B; Zhou G; Gu J
    Thorac Cancer; 2022 Jul; 13(13):1961-1973. PubMed ID: 35599381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells.
    Demers M; Rose AA; Grosset AA; Biron-Pain K; Gaboury L; Siegel PM; St-Pierre Y
    Am J Pathol; 2010 Jun; 176(6):3023-31. PubMed ID: 20382700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
    André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
    J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Galectins in Tumors and in Clinical Immunotherapy.
    Chou FC; Chen HY; Kuo CC; Sytwu HK
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor galectinology: insights into the complex network of a family of endogenous lectins.
    Lahm H; André S; Hoeflich A; Kaltner H; Siebert HC; Sordat B; von der Lieth CW; Wolf E; Gabius HJ
    Glycoconj J; 2004; 20(4):227-38. PubMed ID: 15115907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer.
    Jung EJ; Moon HG; Cho BI; Jeong CY; Joo YT; Lee YJ; Hong SC; Choi SK; Ha WS; Kim JW; Lee CW; Lee JS; Park ST
    Int J Cancer; 2007 Jun; 120(11):2331-8. PubMed ID: 17304502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Galectin-9 Treatment on the Phenotype and Function of NK-92MI Cells in the Presence of Different Serum Supplements.
    Meggyes M; Nagy DU; Balassa T; Godony K; Peterfalvi A; Szereday L; Polgar B
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies.
    Kapetanakis NI; Busson P
    Front Immunol; 2023; 14():1145268. PubMed ID: 36817445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
    Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
    Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease.
    Carlsson MC; Balog CI; Kilsgård O; Hellmark T; Bakoush O; Segelmark M; Fernö M; Olsson H; Malmström J; Wuhrer M; Leffler H
    Biochim Biophys Acta; 2012 Sep; 1820(9):1366-72. PubMed ID: 22285770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum galectin-3 levels in patients with psoriasis.
    Hayran Y; Allı N; Akpınar Ü; Öktem A; Yücel Ç; Fırat Oguz E; Turhan T
    Int J Clin Pract; 2021 Oct; 75(10):e14545. PubMed ID: 34137138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients.
    Trebo A; Ditsch N; Kuhn C; Heidegger HH; Zeder-Goess C; Kolben T; Czogalla B; Schmoeckel E; Mahner S; Jeschke U; Hester A
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer.
    Irie A; Yamauchi A; Kontani K; Kihara M; Liu D; Shirato Y; Seki M; Nishi N; Nakamura T; Yokomise H; Hirashima M
    Clin Cancer Res; 2005 Apr; 11(8):2962-8. PubMed ID: 15837748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer.
    Yasinska IM; Sakhnevych SS; Pavlova L; Teo Hansen Selnø A; Teuscher Abeleira AM; Benlaouer O; Gonçalves Silva I; Mosimann M; Varani L; Bardelli M; Hussain R; Siligardi G; Cholewa D; Berger SM; Gibbs BF; Ushkaryov YA; Fasler-Kan E; Klenova E; Sumbayev VV
    Front Immunol; 2019; 10():1594. PubMed ID: 31354733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.